• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非囊性纤维化支气管扩张症

Non-cystic fibrosis bronchiectasis.

作者信息

Smith M P

机构信息

Royal Infirmary of Edinburgh, 51 Little France Crescent, Old Dalkeith Road, Edinburgh, UK.

出版信息

J R Coll Physicians Edinb. 2011 Jun;41(2):132-9; quiz 139. doi: 10.4997/JRCPE.2011.217.

DOI:10.4997/JRCPE.2011.217
PMID:21677919
Abstract

Bronchiectasis is a chronic debilitating condition. Pathologically, a vicious cycle of infection and inflammation exists in the permanently damaged airways with patients suffering a persistent cough, chronic daily sputum production and recurrent chest infections. Once termed an 'orphan disease', the prevalence of bronchiectasis has become increasingly recognised over the past few decades. The associated burden of disease in terms of respiratory morbidity, effect on patients' health-related quality of life and the economic cost of long term management is significant and it has become apparent that more research into its causes and management is urgently needed. This article reviews what is currently known about bronchiectasis, its pathophysiology, aetiology and management strategies.

摘要

支气管扩张是一种慢性衰弱性疾病。在病理上,永久性受损的气道中存在感染与炎症的恶性循环,患者会持续咳嗽、每日慢性咳痰并反复出现胸部感染。支气管扩张曾被称为“孤儿病”,在过去几十年中,其患病率越来越受到关注。在呼吸发病率、对患者健康相关生活质量的影响以及长期管理的经济成本方面,相关疾病负担都很显著,显然迫切需要对其病因和管理进行更多研究。本文综述了目前关于支气管扩张及其病理生理学、病因和管理策略的已知情况。

相似文献

1
Non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症
J R Coll Physicians Edinb. 2011 Jun;41(2):132-9; quiz 139. doi: 10.4997/JRCPE.2011.217.
2
Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century.非囊性纤维化性支气管扩张症:21 世纪的诊断与管理。
Postgrad Med J. 2010 Aug;86(1018):493-501. doi: 10.1136/pgmj.2009.091041.
3
Non-cystic fibrosis bronchiectasis.非囊性纤维化性支气管扩张症。
QJM. 2013 Aug;106(8):709-15. doi: 10.1093/qjmed/hct109. Epub 2013 May 30.
4
Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries.儿童非囊性纤维化支气管扩张症:发展中国家的一个持续存在的问题。
Respiration. 2005 May-Jun;72(3):233-8. doi: 10.1159/000085362.
5
Bronchiectasis in children: orphan disease or persistent problem?儿童支气管扩张症:罕见病还是持续性问题?
Pediatr Pulmonol. 2002 Jun;33(6):492-6. doi: 10.1002/ppul.10104.
6
Pediatric bronchiectasis: No longer an orphan disease.小儿支气管扩张症:不再是罕见病。
Pediatr Pulmonol. 2016 May;51(5):450-69. doi: 10.1002/ppul.23380. Epub 2016 Feb 3.
7
Non-cystic fibrosis bronchiectasis.非囊性纤维化性支气管扩张症。
Am J Respir Crit Care Med. 2013 Sep 15;188(6):647-56. doi: 10.1164/rccm.201303-0411CI.
8
Bronchiectasis in children.儿童支气管扩张症
Pediatr Clin North Am. 2009 Feb;56(1):157-71, xi. doi: 10.1016/j.pcl.2008.10.014.
9
Bronchiectasis.支气管扩张症
Intern Med J. 2006 Nov;36(11):729-37. doi: 10.1111/j.1445-5994.2006.01219.x.
10
Exacerbations in cystic fibrosis: 4--Non-cystic fibrosis bronchiectasis.囊性纤维化的病情加重:4——非囊性纤维化支气管扩张症
Thorax. 2008 Mar;63(3):269-76. doi: 10.1136/thx.2006.060913.

引用本文的文献

1
Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment.用于非囊性纤维化支气管扩张症治疗的环丙沙星吸入式纳米结构脂质载体的研制。
Int J Nanomedicine. 2021 Mar 25;16:2405-2417. doi: 10.2147/IJN.S286896. eCollection 2021.
2
A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial.一项 2×2 析因、随机、开放标签临床试验,旨在确定高渗盐水(HTS 6%)和羧甲司坦用于气道清除相对于常规护理在 52 周内对支气管扩张症成人的临床和成本效益:CLEAR 临床试验的方案。
Trials. 2019 Dec 19;20(1):747. doi: 10.1186/s13063-019-3766-9.
3
Challenges of diagnosing and managing bronchiectasis in resource-limited settings: a case study.资源有限环境下支气管扩张症的诊断与管理挑战:一项案例研究
Pan Afr Med J. 2019 Feb 18;32:82. doi: 10.11604/pamj.2019.32.82.18167. eCollection 2019.
4
Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.长期红霉素治疗对非囊性纤维化支气管扩张患者口咽部微生物组和耐药基因库的影响。
mSphere. 2018 Apr 18;3(2). doi: 10.1128/mSphere.00103-18. Print 2018 Apr 25.
5
Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.非结核分枝杆菌病在非囊性纤维化支气管扩张症患者中很常见。
Int J Infect Dis. 2013 Nov;17(11):e1000-4. doi: 10.1016/j.ijid.2013.03.018. Epub 2013 May 16.
6
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study.吸入用环丙沙星干粉在非囊性纤维化支气管扩张症中的应用:一项 II 期随机研究。
Eur Respir J. 2013 May;41(5):1107-15. doi: 10.1183/09031936.00071312. Epub 2012 Sep 27.